Thanks Hurley. I have little doubt, this will be the one stock, I will tell stories about, in just few years from now.
Honestly, studying many biotech companies, from what I understand, $VCEL has very small market cap, comparing to the number of the product, and the quality and uniqueness of them.
Other companies dilute so many time, and create debt, and they are already at billions of dollars, and yet to be profitable, having products with many comparable.
This might be a very rare opportunity to make many times our money, in a very short period of time. I'm feel that I'm right, and I may be able to retire on this one.
Again, it's solely in Nick's hand. He seems to be doing things right so far, by keeping costs down, not issues right just to raise some capital, ...
The only thing I don't understand is that although MACI is a very unique solution, why is it sold at such discount price. (I remember lasers mentioned there is $1000 net profit on MACI per procedure)
Other companies sell orphan drug for up to hundreds of thousands.
I'm not arguing that the price of the product should be higher, and just trying to understand how do they come up with prices.
News 
Market Data 
Discover 
